Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
- PMID: 15961076
- DOI: 10.1016/j.yexmp.2005.05.001
Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
Abstract
Elevated amounts of cell-free nucleic acids are detected in the circulation of cancer patients. The type and pattern of these may vary depending on the origin. Recently, we described the presence of circulating fragmented nucleosomal DNA. In the present study, our aim was to investigate the association between nucleosomal DNA, caspase-3 expression and circulating caspase-3 mRNA, the primary activator of nucleosomal DNA fragmentation. DNA fragmentation was analyzed by gel electrophoresis, and caspase-3 was analyzed by RT-PCR. Plasma samples from 65% of patients were positive for nucleosomal DNA fragmentation, whereas none of the healthy controls showed DNA fragmentation (P = 0.0004). Expression of caspase-3 differed significantly between the cases and controls (P < 0.0001). However, we observed no direct correlation between nucleosomal DNA fragmentation and caspase-3 expression in lymphocytes (P = 0.145). Circulating plasma caspase-3 mRNA was detected by nested RT-PCR, and no significant difference was observed between the patients and the control group (P = 0.5). Our results indicate that caspase-3 expression is increased in lymphocytes from patients. When compared to healthy individuals, no differences were observed in the amount of circulating mRNA. These findings suggest that nucleosomal DNA fragmentation is not correlated with elevated levels of apoptosis and circulating caspase-3 mRNA in circulating tumor cells.
Similar articles
-
Nucleosomal DNA fragments in autoimmune diseases.Ann N Y Acad Sci. 2006 Sep;1075:318-27. doi: 10.1196/annals.1368.043. Ann N Y Acad Sci. 2006. PMID: 17108227
-
Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients.Clin Chim Acta. 2003 Sep;335(1-2):89-94. doi: 10.1016/s0009-8981(03)00279-1. Clin Chim Acta. 2003. PMID: 12927689
-
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.Breast Cancer Res Treat. 2006 May;97(1):49-55. doi: 10.1007/s10549-005-9086-7. Breast Cancer Res Treat. 2006. PMID: 16319978
-
Circulating nucleic acids in cancer and pregnancy.Methods. 2010 Apr;50(4):302-7. doi: 10.1016/j.ymeth.2010.02.004. Epub 2010 Feb 8. Methods. 2010. PMID: 20146940 Review.
-
[Generation of blood circulating DNA: the sources, peculiarities of circulation and structure].Biomed Khim. 2015 Jul-Aug;61(4):409-26. doi: 10.18097/PBMC20156104409. Biomed Khim. 2015. PMID: 26350732 Review. Russian.
Cited by
-
Expression of the TRAIL receptors in blood mononuclear cells in leukemia.Pathol Oncol Res. 2007;13(4):290-4. doi: 10.1007/BF02940307. Epub 2007 Dec 25. Pathol Oncol Res. 2007. PMID: 18158563
-
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.Br J Cancer. 2011 Feb 15;104(4):719-25. doi: 10.1038/sj.bjc.6606082. Epub 2011 Jan 18. Br J Cancer. 2011. PMID: 21245866 Free PMC article.
-
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.Transl Oncol. 2013 Jun 1;6(3):319-28. doi: 10.1593/tlo.12445. Print 2013 Jun. Transl Oncol. 2013. PMID: 23730412 Free PMC article.
-
Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood.Clin Chem. 2014 Mar;60(3):500-9. doi: 10.1373/clinchem.2013.214874. Epub 2013 Nov 22. Clin Chem. 2014. PMID: 24270796 Free PMC article.
-
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.Int J Mol Sci. 2018 Aug 24;19(9):2514. doi: 10.3390/ijms19092514. Int J Mol Sci. 2018. PMID: 30149597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials